Richardson Financial Services Inc. Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Richardson Financial Services Inc. purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, HoldingsChannel reports. The firm purchased 1,095 shares of the company’s stock, valued at approximately $296,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Stone House Investment Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at about $25,000. Centerpoint Advisors LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $28,000. Finally, FinTrust Capital Advisors LLC grew its position in HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after buying an additional 35 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HCA shares. Oppenheimer lifted their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Robert W. Baird started coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target for the company. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday. TD Cowen cut their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research note on Friday, April 12th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $325.59.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the completion of the transaction, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now directly owns 19,612 shares in the company, valued at $6,397,042.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,617 shares of company stock valued at $4,321,986. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 0.8 %

HCA stock traded down $2.76 during trading on Friday, hitting $337.47. The company had a trading volume of 747,441 shares, compared to its average volume of 935,055. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The firm has a 50-day moving average price of $320.68 and a 200-day moving average price of $313.21. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $343.53. The stock has a market cap of $88.39 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 1.56 and a beta of 1.69.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the previous year, the company posted $4.93 EPS. HCA Healthcare’s revenue was up 11.2% on a year-over-year basis. As a group, analysts predict that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.